| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 47 |
| 1 | VEDOLIZUMAB | 47 |
| 2 | LENALIDOMIDE | 46 |
| 3 | PANTOPRAZOLE | 29 |
| 4 | CHOLESTYRAMINE | 23 |
| 5 | DEXAMETHASONE | 23 |
| 6 | DEXAMETHASONE 1.5 MG | 23 |
| 7 | ADALIMUMAB-AATY | 22 |
| 8 | ADALIMUMAB-ADAZ | 22 |
| 9 | ADALIMUMAB-FKJP | 22 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COLESEVELAM HYDROCHLORIDE | 9 | 0.0084 |
| 1 | HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE | 1 | 0.0047 |
| 2 | CUPRIC CHLORIDE | 2 | 0.0027 |
| 3 | ODEVIXIBAT | 1 | 0.0025 |
| 4 | MARALIXIBAT CHLORIDE | 2 | 0.0020 |
| 5 | CHOLESTYRAMINE | 23 | 0.0019 |
| 6 | CHLORZOXAZONE | 2 | 0.0015 |
| 7 | PSYLLIUM HUSK | 2 | 0.0015 |
| 8 | I. V. FAT EMULSION | 1 | 0.0014 |
| 9 | PURIXAN | 1 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 51 |
| 1 | Integrin Receptor Antagonist [EPC] | 47 |
| 2 | Thalidomide Analog [EPC] | 47 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 32 |
| 4 | GLP-1 Receptor Agonist [EPC] | 31 |
| 5 | Interleukin-23 Antagonist [EPC] | 27 |
| 6 | Bile Acid Sequestrant [EPC] | 23 |
| 7 | Proteasome Inhibitor [EPC] | 22 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 17 |
| 9 | Anti-epileptic Agent [EPC] | 16 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 3 | 0.0044 |
| 1 | Ileal Bile Acid Transporter Inhibitor [EPC] | 1 | 0.0022 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 12 | 0.0021 |
| 3 | Bile Acid Sequestrant [EPC] | 23 | 0.0019 |
| 4 | Somatostatin Analog [EPC] | 11 | 0.0016 |
| 5 | Integrin Receptor Antagonist [EPC] | 47 | 0.0005 |
| 6 | Non-Standardized Insect Allergenic Extract [EPC] | 3 | 0.0005 |
| 7 | Standardized Insect Venom Allergenic Extract [EPC] | 3 | 0.0004 |
| 8 | Lipid Emulsion [EPC] | 1 | 0.0004 |
| 9 | Provitamin D2 Compound [EPC] | 8 | 0.0003 |